CPT® Code 78803

Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging

The CPT® Code 78803 refers to a diagnostic imaging procedure known as radiopharmaceutical localization, which utilizes molecular imaging techniques, specifically single photon emission computed tomography (SPECT). This procedure is designed to identify and localize tumors or inflammatory processes within the body by employing a radiolabeled isotope tracer. The tracer is engineered to bind to specific cells or tissues, allowing for the detection of inflammation or neoplastic growths, even in their early stages. The process begins with the establishment of an intravenous line, through which the radiolabeled isotope is injected directly into the patient's circulatory system. Alternatively, a blood sample may be taken, and the white or red blood cells can be separated and tagged with the isotope before being reintroduced into the patient. In some cases, radioactive agents may also be inhaled or ingested to facilitate distribution throughout the body. Once administered, the tracer circulates and localizes in areas of interest, such as inflamed or tumorous tissues. The patient is then positioned on an imaging table, and a specialized gamma camera is used to capture images of the targeted area, rotating around the patient to obtain comprehensive views. This imaging technique can include blood pool imaging, which visualizes the flow of the radioactive tracer through the area of interest. The resulting images provide valuable insights into the size, volume, and physiological processes of the target tissue. Ultimately, the physician interprets the findings from the SPECT imaging and generates a detailed written report, contributing to the overall diagnostic process.